The introduction of antibiotics subsequently transformed the healthcare industry bringing on the table seve...
Beam adds to drug delivery stable with USD 120 Million GuideTx buyBeam Therapeutics has taken over a startup whose technology could proffer the biotech’s genetic medicines to more tissues in t...
Plaque psoriasis drug outshines the competition in phase III trialBristol Myers Squibb’s psoriasis drug, the TYK2 inhibitor outshone placebo and Amgen’s Otezla in a second phase 3 study, setti...
Horizon Therapeutics Bolsters its Rare Disease Portfolio in a $3B Viela Bio BuyoutHorizon Therapeutics has announced to acquire Viela Bio for about $3.1 billion to augment its portfolio and pi...
Hallux Valgus, also know as Bunion, is the most common forefoot problem in adults. It is the most common pathologic entity of the big toe. It refers to the progressive swelling of the soft tissue....
Bristol Myers' Experimental Psoriasis drug succeeds in late-stage study defeats rival Amgen's OtezlaBristol Myers' experimental psoriasis drug, deucravacitinib has outmarched Amgen's Otezla (a...
Epidermolysis bullosa (EB) places a significant socioeconomic burden on patients. Several reports stated that Epidermolysis bullosa had a considerable negative impact on the quality of the lives o...
According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....
Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....
Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....
Data and analytics today are playing a major role in the organization’s growth. Stakeho...
Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...
The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...
Neurological disorders are one of the major causes of death and disability across the g...
As per the American Autoimmune Related Diseases Association (AARDA), nearly 50 million ...
